Surgery Partners, Inc. (NASDAQ:SGRY) Short Interest Down 17.6% in November
Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) was the target of a large decrease in short interest in November. As of November 30th, there was short interest totalling 6,440,000 shares, a decrease of 17.6% from the November 15th total of 7,820,000 shares. Approximately 9.9% of the company’s shares are sold short. Based on an average daily trading volume, of 866,400 shares, the short-interest ratio is currently 7.4 days.
Surgery Partners Stock Down 8.3 %
Shares of NASDAQ SGRY traded down $2.93 during mid-day trading on Friday, hitting $32.45. The company had a trading volume of 3,149,917 shares, compared to its average volume of 743,628. The company has a market capitalization of $4.10 billion, a PE ratio of -101.41 and a beta of 2.86. The firm has a 50-day simple moving average of $28.60 and a two-hundred day simple moving average of $33.96. The company has a current ratio of 1.75, a quick ratio of 1.61 and a debt-to-equity ratio of 0.88. Surgery Partners has a one year low of $22.05 and a one year high of $45.79.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last issued its earnings results on Tuesday, November 7th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.05. Surgery Partners had a negative net margin of 1.26% and a positive return on equity of 2.70%. The business had revenue of $674.10 million during the quarter, compared to the consensus estimate of $670.74 million. On average, equities analysts expect that Surgery Partners will post 0.73 EPS for the current year.
Institutional Investors Weigh In On Surgery Partners
Several hedge funds have recently bought and sold shares of the company. Ameritas Investment Partners Inc. lifted its position in Surgery Partners by 8.0% during the first quarter. Ameritas Investment Partners Inc. now owns 4,131 shares of the company’s stock worth $142,000 after acquiring an additional 305 shares during the last quarter. PNC Financial Services Group Inc. lifted its position in Surgery Partners by 34.7% during the first quarter. PNC Financial Services Group Inc. now owns 1,195 shares of the company’s stock worth $66,000 after acquiring an additional 308 shares during the last quarter. Rockefeller Capital Management L.P. lifted its position in Surgery Partners by 35.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 1,709 shares of the company’s stock worth $47,000 after acquiring an additional 449 shares during the last quarter. Lazard Asset Management LLC acquired a new stake in Surgery Partners during the second quarter worth approximately $27,000. Finally, Metropolitan Life Insurance Co NY lifted its position in Surgery Partners by 25.9% during the fourth quarter. Metropolitan Life Insurance Co NY now owns 3,025 shares of the company’s stock worth $84,000 after acquiring an additional 622 shares during the last quarter.
Wall Street Analysts Forecast Growth
SGRY has been the subject of a number of research reports. TheStreet upgraded Surgery Partners from a “d+” rating to a “c-” rating in a report on Friday, December 1st. TD Cowen upgraded Surgery Partners from a “market perform” rating to an “outperform” rating and lowered their target price for the stock from $39.00 to $35.00 in a report on Tuesday, November 14th. Benchmark reiterated a “buy” rating and set a $50.00 target price on shares of Surgery Partners in a report on Thursday, October 12th. Cantor Fitzgerald reiterated an “overweight” rating and set a $43.00 target price on shares of Surgery Partners in a report on Thursday, September 14th. Finally, StockNews.com upgraded Surgery Partners from a “sell” rating to a “hold” rating in a report on Wednesday. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $45.13.
Check Out Our Latest Stock Analysis on SGRY
Surgery Partners Company Profile (Get Free Report)
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Surgery Partners, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Surgery Partners wasn’t on the list.
While Surgery Partners currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Original: MarketBeat News Feed: Surgery Partners, Inc. (NASDAQ:SGRY) Short Interest Down 17.6% in November